Skip to main content
SpringerLink
Log in

Liver Transplantation

  • Chapter
  • First Online:
Diseases of the Liver in Children

Abstract

In the past half century, liver transplantation has become the standard of care not only for children with end-stage liver disease but also for children with metabolic diseases manifested largely outside of the liver. Significant improvements have been made in patient and graft survival, such that 1-year survival for children following liver transplantation is greater than 90 %.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kim WR, Stock PG, Smith JM, Heimbach JK, Skeans MA, Edwards EB, et al. OPTN/SRTR 2011 Annual Data Report: Liver. Am J Transplant. 2013;13(1):73–102.

    Google Scholar 

  2. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659–76.

    PubMed  CAS  PubMed Central  Google Scholar 

  3. Calne RY. Early days of liver transplantation. Am J Transplant. 2008;8(9):1775–8.

    PubMed  CAS  Google Scholar 

  4. Starzl TE, Koep LJ, Schröter GP, Halgrimson CG, Porter KA, Weil R. Liver replacement for pediatric patients. Pediatrics. 1979;63(6):825–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  5. Mcdiarmid SV, Anand R, Lindblad AS, Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation SPLIT Research Group. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation. 2002;74(2):173–81.

    PubMed  Google Scholar 

  6. Freeman RB, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant. 2004;4 Suppl 9:114–31.

    PubMed  Google Scholar 

  7. Shneider BL, Neimark E, Frankenberg T, Arnott L, Suchy FJ, Emre S. Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience. Liver Transpl. 2005;11(7):788–95.

    PubMed  Google Scholar 

  8. Caton AR. Exploring the seasonality of birth defects in the New York State Congenital Malformations Registry. Birth Defects Res A Clin Mol Teratol. 2012;94(6):424–37.

    PubMed  CAS  Google Scholar 

  9. Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard JL, Auvert B. Epidemiology of biliary atresia in France: a national study 1986–96. J Hepatol. 1999;31(6):1006–13.

    PubMed  CAS  Google Scholar 

  10. Livesey E, Borja MC, Sharif K, Alizai N, Mcclean P, Kelly D, et al. Epidemiology of biliary atresia in England and Wales (1999–2006). Arch Dis Child Fetal Neonatal Ed. 2009;94(6):F451–5.

    PubMed  CAS  Google Scholar 

  11. Yoon PW, Bresee JS, Olney RS, James LM, Khoury MJ. Epidemiology of biliary atresia: a population-based study. Pediatrics. 1997;99(3):376–82.

    PubMed  CAS  Google Scholar 

  12. Girard M, Jannot A-S, Besnard M, Jacquemin E, Henrion-Caude A. Biliary atresia: does ethnicity matter? J Hepatol. 2012;57(3):700–1.

    PubMed  Google Scholar 

  13. Chardot C, Serinet M-O. Prognosis of biliary atresia: what can be further improved? J Pediatr. 2006;148(4):432–5.

    PubMed  Google Scholar 

  14. Vilca Melendez H, Vougas V, Muiesan P, Andreani P, Mieli-Vergani G, Rela M, et al. Bowel perforation after paediatric orthotopic liver transplantation. Transpl Int. 1998;11(4):301–4.

    PubMed  CAS  Google Scholar 

  15. Chen CL, Concejero A, Wang CC, Wang SH, Lin C-C, Liu YW, et al. Living donor liver transplantation for biliary atresia: a single-center experience with first 100 cases. Am J Transplant. 2006;6(11):2672–9.

    PubMed  Google Scholar 

  16. Broering DC, Kim J-S, Mueller T, Fischer L, Ganschow R, Bicak T, et al. One hundred thirty-two consecutive pediatric liver transplants without hospital mortality. Ann Surg. 2004;240(6):1002–12.

    PubMed  PubMed Central  Google Scholar 

  17. Diem HVT, Evrard V, Vinh HT, Sokal EM, Janssen M, Otte JB, et al. Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. Transplantation. 2003;75(10):1692–7.

    PubMed  Google Scholar 

  18. Fouquet V, Alves A, Branchereau S, Grabar S, Debray D, Jacquemin E, et al. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl. 2005;11(2):152–60.

    PubMed  Google Scholar 

  19. Darwish AA, Bourdeaux C, Kader HA, Janssen M, Sokal E, Lerut J, et al. Pediatric liver transplantation using left hepatic segments from living related donors: surgical experience in 100 recipients at Saint-Luc University Clinics. Pediatr Transplant. 2006;10(3):345–53.

    PubMed  Google Scholar 

  20. Utterson EC, Shepherd RW, Sokol RJ, Bucuvalas J, Magee JC, McDiarmid SV, et al. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr. 2005;147(2):180–5.

    PubMed  Google Scholar 

  21. Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Orthotopic liver transplantation for biliary atresia: the U.S. experience. Liver Transpl. 2005;11(10):1193–200.

    PubMed  Google Scholar 

  22. Bhadri VA, Stormon MO, Arbuckle S, Lam AH, Gaskin KJ, Shun A. Hepatocellular carcinoma in children with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2005;41(5):676–8.

    PubMed  Google Scholar 

  23. Hadžić N, Quaglia A, Portmann B, Paramalingam S, Heaton ND, Rela M, et al. Hepatocellular carcinoma in biliary atresia: King’s College Hospital experience. J Pediatr. 2011;159(4):617–22.e1.

    PubMed  Google Scholar 

  24. Ng VL, Fecteau A, Shepherd R, Magee J, Bucuvalas J, Alonso E, et al. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a North American Multicenter Registry. Pediatrics. 2008;122(6):e1128–35.

    PubMed  Google Scholar 

  25. Peeters PMJG, Sieders E, De Jong KP, Bijleveld CMA, Hendriks HGD, Ten Vergert EM, et al. Comparison of outcome after pediatric liver transplantation for metabolic diseases and biliary atresia. Eur J Pediatr Surg. 2001;11(1):28–35. Georg Thieme Verlag/Masson Editeur: Stuttart, New York/Paris.

    PubMed  CAS  Google Scholar 

  26. Leonard JV, Walter JH, McKiernan PJ. The management of organic acidaemias: the role of transplantation. J Inherit Metab Dis. 2001;24:309–11.

    PubMed  CAS  Google Scholar 

  27. Shneider BL, Vockley J, Mazariegos GV. Trading places: liver transplantation as a treatment, not a cure, for metabolic liver disease. Liver Transpl. 2011;17(6):628–30.

    PubMed  Google Scholar 

  28. Vara R, Turner C, Mundy H, Heaton ND, Rela M, Mieli-Vergani G, et al. Liver transplantation for propionic acidemia in children. Liver Transpl. 2011;17(6):661–7.

    PubMed  Google Scholar 

  29. Whitington PF, Alonso EM, Boyle JT, Molleston JP, Rosenthal P, Emond JC, et al. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis. 1998;21 Suppl 1:112–8.

    PubMed  Google Scholar 

  30. Arnon R, Kerkar N, Davis MK, Anand R, Yin W, González-Peralta RP. Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience. Pediatr Transplant. 2010;14(6):796–805.

    PubMed  Google Scholar 

  31. Kayler LK, Rasmussen CS, Dykstra DM, Punch JD, Rudich SM, Magee JC, et al. Liver transplantation in children with metabolic disorders in the United States. Am J Transplant. 2003;3(3):334–9.

    PubMed  Google Scholar 

  32. Baliga P, Alvarez S, Lindblad A, Zeng L, Studies of Pediatric Liver Transplantation Research Group. Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience. Liver Transpl. 2004;10(11):1364–71.

    PubMed  Google Scholar 

  33. Squires Jr RH, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652–8.

    PubMed  PubMed Central  Google Scholar 

  34. Miloh T, Kerkar N, Parkar S, Emre S, Annunziato R, Mendez C, et al. Improved outcomes in pediatric liver transplantation for acute liver failure. Pediatr Transplant. 2010;14(7):863–9.

    PubMed  Google Scholar 

  35. Futagawa Y, Terasaki PI. An analysis of the OPTN/UNOS Liver Transplant Registry. Clin Transpl. 2004:315–29.

    Google Scholar 

  36. Farmer DG, Venick RS, Mcdiarmid SV, Duffy JP, Kattan O, Hong JC, et al. Fulminant hepatic failure in children: superior and durable outcomes with liver transplantation over 25 years at a single center. Ann Surg. 2009;250(3):484–93.

    PubMed  Google Scholar 

  37. Austin MT, Leys CM, Feurer ID, Lovvorn HN, O'Neill JA, Pinson CW, et al. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg. 2006;41(1):182–6.

    PubMed  Google Scholar 

  38. Guiteau JJ, Cotton RT, Karpen SJ, O’mahony CA, Goss JA. Pediatric liver transplantation for primary malignant liver tumors with a focus on hepatic epithelioid hemangioendothelioma: The UNOS experience. Pediatr Transplant. 2010;14(3):326–31.

    PubMed  Google Scholar 

  39. Avila L, Luis A, Hernandez F, Garcia-Miguel P, Jara P, Andres A, et al. Liver transplantation for malignant tumours in children. Eur J Pediatr Surg. 2006;16(6):411–4. Georg Thieme Verlag KG Stuttgart/Masson Editeur: New York/Paris.

    PubMed  CAS  Google Scholar 

  40. Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer. 2003;42(1):74–83.

    Google Scholar 

  41. Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, et al. Survival after liver transplantation for hepatoblastoma: a 2-center experience. J Pediatr Surg. 2008;43(11):1973–81.

    PubMed  Google Scholar 

  42. Otte JB, Meyers R. PLUTO First report. Pediatr Transplant. 2010;14(7):830–5.

    PubMed  Google Scholar 

  43. Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis. 2000;30(6):857–69.

    PubMed  CAS  Google Scholar 

  44. Campbell AL, Herold BC. Immunization of pediatric solid-organ transplantation candidates: immunizations in transplant candidates. Pediatr Transplant. 2005;9(5):652–61.

    PubMed  Google Scholar 

  45. Abuali MM, Arnon R, Posada R. An update on immunizations before and after transplantation in the pediatric solid organ transplant recipient. Pediatr Transplant. 2011;15(8):770–7.

    PubMed  CAS  Google Scholar 

  46. Greer R, Lehnert M, Lewindon P, Cleghorn GJ, Shepherd RW. Body composition and components of energy expenditure in children with end-stage liver disease. J Pediatr Gastroenterol Nutr. 2003;36(3):358–63.

    PubMed  Google Scholar 

  47. Sokol RJ, Stall C. Anthropometric evaluation of children with chronic liver disease. Am J Clin Nutr. 1990;52(2):203–8.

    PubMed  CAS  Google Scholar 

  48. DeRusso PA, Ye W, Shepherd R, Haber BA, Shneider BL, Whitington PF, et al. Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology. 2007;46(5):1632–8.

    PubMed  Google Scholar 

  49. Shepherd RW, Chin SE, Cleghorn GJ, Patrick M, Ong TH, Lynch SV, et al. Malnutrition in children with chronic liver disease accepted for liver transplantation: clinical profile and effect on outcome. J Paediatr Child Health. 1991;27(5):295–9.

    PubMed  CAS  Google Scholar 

  50. Sullivan JS, Sundaram SS, Pan Z, Sokol RJ. Parenteral nutrition supplementation in biliary atresia patients listed for liver transplantation. Liver Transpl. 2012;18(1):120–8.

    PubMed  PubMed Central  Google Scholar 

  51. Guimber D, Michaud L, Ategbo S, Turck D, Gottrand F. Experience of parenteral nutrition for nutritional rescue in children with severe liver disease following failure of enteral nutrition. Pediatr Transplant. 1999;3(2):139–45.

    PubMed  CAS  Google Scholar 

  52. Broelsch CE, Emond JC, Thistlethwaite JR, Whitington PF, Zucker AR, Baker AL, et al. Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg. 1988;208(4):410–20.

    PubMed  CAS  PubMed Central  Google Scholar 

  53. Emond JC, Whitington PF, Thistlethwaite JR, Cherqui D, Alonso EA, Woodle IS, et al. Transplantation of two patients with one liver. Analysis of a preliminary experience with “split-liver” grafting. Ann Surg. 1990;212(1):14–22.

    PubMed  CAS  PubMed Central  Google Scholar 

  54. Broelsch CE. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg. 1990;212(3):368. Lippincott, Williams, and Wilkins.

    PubMed  CAS  PubMed Central  Google Scholar 

  55. Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med. 1990;322(21):1505–7.

    PubMed  CAS  Google Scholar 

  56. Abt PL, Rapaport-Kelz R, Desai NM, Frank A, Sonnad S, Rand E, et al. Survival among pediatric liver transplant recipients: impact of segmental grafts. Liver Transpl. 2004;10(10):1287–93.

    PubMed  Google Scholar 

  57. Becker NS, Barshes NR, Aloia TA, Nguyen T, Rojo J, Rodriguez JA, et al. Analysis of recent pediatric orthotopic liver transplantation outcomes indicates that allograft type is no longer a predictor of survivals. Liver Transpl. 2008;14(8):1125–32.

    PubMed  Google Scholar 

  58. Sunku B, Salvalaggio PRO, Donaldson JS, Rigsby CK, Neighbors K, Superina RA, et al. Outcomes and risk factors for failure of radiologic treatment of biliary strictures in pediatric liver transplantation recipients. Liver Transpl. 2006;12(5):821–6.

    PubMed  Google Scholar 

  59. Peclet MH, Ryckman FC, Pedersen SH, Dittrich VS, Heubi JE, Farrell M, et al. The spectrum of bile duct complications in pediatric liver transplantation. J Pediatr Surg. 1994;29(2):214–20.

    PubMed  CAS  Google Scholar 

  60. Kerkar N, Morotti RA, Iyer K, Arnon R, Miloh T, Sturdevant M, et al. Anti-lymphocyte therapy successfully controls late “cholestatic” rejection in pediatric liver transplant recipients. Clin Transplant. 2011;25(6):E584–91.

    PubMed  CAS  Google Scholar 

  61. Cohran VC, Griffiths M, Heubi JE. Bone mineral density in children exposed to chronic glucocorticoid therapy. Clin Pediatr. 2008;47(5):469–75.

    Google Scholar 

  62. Ng VL, Alonso EM, Bucuvalas JC, Cohen G, Limbers CA, Varni JW, et al. Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. J Pediatr. 2011;160:820–6.

    PubMed  Google Scholar 

  63. Alonso EM, Shepherd R, Martz KL, Yin W, Anand R. Linear growth patterns in prepubertal children following liver transplantation. Am J Transplant. 2009;9(6):1389–97.

    PubMed  CAS  Google Scholar 

  64. Diem HVT, Sokal EM, Janssen M, Otte JB, Reding R. Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients. Transplantation. 2003;75(10):1664–70.

    PubMed  Google Scholar 

  65. The US Multicenter FK 506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med. 1994;331(17):1110–5.

    Google Scholar 

  66. Goto T, Kino T, Hatanaka H, Nishiyama M, Okuhara M, Kohsaka M, et al. Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Soc. 1987;19(5 Suppl 6):4–8.

    CAS  Google Scholar 

  67. Armitage JM, et al. The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric Cardiac transplantation. Transplant Proc. 1991;23(6):3058.

    PubMed  CAS  PubMed Central  Google Scholar 

  68. Tzakis AG, et al. Two-year experience with FK 506 in pediatric patients. Transplant Proc. 1993;25(1 Pt 1):619.

    PubMed  CAS  PubMed Central  Google Scholar 

  69. Horslen S, Barr ML, Christensen LL, Ettenger R, Magee JC. Pediatric transplantation in the United States, 1996–2005. Am J Transplant. 2007;7(s1):1339–58.

    PubMed  CAS  Google Scholar 

  70. Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation. 2000;70(4):617–25.

    PubMed  CAS  PubMed Central  Google Scholar 

  71. Campbell K, Ng V, Martin S, Magee J, Goebel J, Anand R, et al. Glomerular filtration rate following pediatric liver transplantation – the SPLIT experience. Am J Transplant. 2010;10(12):2673–82.

    PubMed  CAS  Google Scholar 

  72. Lobritto SJ, Rosenthal P, Bouw R, Leung M, Snell P, Mamelok RD. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine. Liver Transpl. 2007;13(11):1570–5.

    PubMed  Google Scholar 

  73. Barau C, Barrail-Tran A, Hemerziu B, Habes D, Taburet A-M, Debray D, et al. Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients. Liver Transpl. 2011;17(10):1152–8.

    PubMed  Google Scholar 

  74. Barau C, Furlan V, Debray D, Taburet A-M, Barrail-Tran A. Population pharmacokinetics of mycophenolic acid and dose optimisation with limited sampling strategy in liver transplant children. Br J Clin Pharmacol. 2012;74(3):515–24.

    PubMed  CAS  PubMed Central  Google Scholar 

  75. Gibelli NEM, Tannuri U, Pinho-Apezzato ML, Tannuri ACA, Maksoud-Filho JG, Andrade WC, et al. Sirolimus in pediatric liver transplantation: a single-center experience. Transplant Soc. 2010;41(3):901–3.

    Google Scholar 

  76. Sindhi R, Seward J, Mazariegos G, Soltys K, Seward L, Smith A, et al. Replacing calcineurin inhibitors with mTOR inhibitors in children. Pediatr Transplant. 2005;9(3):391–7.

    PubMed  CAS  Google Scholar 

  77. Czubkowski P, Pawłowska J, Jankowska I, Teisseyre M, Kamińska D, Markiewicz M, et al. Successful sirolimus rescue in tacrolimus-induced thrombotic microangiopathy after living-related liver transplantation. Pediatr Transplant. 2012;16(6):E261–4.

    PubMed  Google Scholar 

  78. Dunkelberg J. Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications. Liver Transpl. 2003;9(5):463–8.

    PubMed  Google Scholar 

  79. Campsen J, Zimmerman MA, Mandell S, Kaplan M, Kam I. A decade of experience using mTor inhibitors in liver transplantation. J Transplant. 2011;2011:1–7.

    Google Scholar 

  80. Sanchez EQ, Martin AP, Ikegami T, Uemura T, Narasimhan G, Goldstein RM, et al. Sirolimus conversion after liver transplantation: improvement in measured glomerular filtration rate after 2 years. Transplant Proc. 2005;37(10):4416–23.

    PubMed  CAS  Google Scholar 

  81. Jiménez-Rivera C, Avitzur Y, Fecteau AH, Jones N, Grant D, Ng VL. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Pediatr Transplant. 2004;8(3):243–8.

    PubMed  Google Scholar 

  82. Filippone EJ, Carson JM, Beckford RA, Jaffe BC, Newman E, Awsare BK, et al. Sirolimus-induced pneumonitis complicated by pentamidine-induced phospholipidosis in a renal transplant recipient: a case report. Transplant Soc. 2011;43(7):2792–7.

    CAS  Google Scholar 

  83. Roberts RJ, Wells AC, Unitt E, Griffiths M, Tasker AD, Allison ME, et al. Sirolimus-induced pneumonitis following liver transplantation. Liver Transpl. 2007;13(6):853–6.

    PubMed  Google Scholar 

  84. Garrean S, Massad MG, Tshibaka M, Hanhan Z, Caines AE, Benedetti E. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients. Clin Transplant. 2005;19(5):698–703.

    PubMed  Google Scholar 

  85. Nielsen D, Briem-Richter A, Sornsakrin M, Fischer L, Nashan B, Ganschow R. The use of everolimus in pediatric liver transplant recipients: First experience in a single center. Pediatr Transplant. 2011;15(5):510–4.

    PubMed  CAS  Google Scholar 

  86. Martin SR, Atkison P, Anand R, Lindblad AS, Split Research Group. Studies of pediatric liver transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant. 2004;8(3):273–83.

    PubMed  CAS  Google Scholar 

  87. Demetris AJ, Batts KP, Dhillon AP, Ferrell L, Fung J, Geller SA, Hart J, Hayry P, Hofmann WJ, Hubscher S. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997;25:658–63.

    Google Scholar 

  88. Ormonde DG, de Boer WB, Kierath A, Bell R, Shilkin KB, House AK, et al. Banff schema for grading liver allograft rejection: utility in clinical practice. Liver Transpl Surg. 1999;5(4):261–8.

    PubMed  CAS  Google Scholar 

  89. Banff Working Group, Demetris AJ. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006;44(2):489–501.

    PubMed  Google Scholar 

  90. Schmitt TM, Phillips M, Sawyer RG, Northup P, Hagspiel KD, Pruett TL, et al. Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation. Dig Dis Sci. 2010;55(11):3224–34.

    PubMed  CAS  Google Scholar 

  91. Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RA. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology. 1987;7(3):476–83.

    PubMed  CAS  Google Scholar 

  92. Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11(3):500–10.

    PubMed  CAS  PubMed Central  Google Scholar 

  93. Ali S, Ormsby A, Shah V, Segovia MC, Kantz KL, Skorupski S, et al. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection. Transpl Immunol. 2012;26(1):62–9.

    PubMed  CAS  Google Scholar 

  94. Lumbreras C, Lizasoain M, Moreno E, Aguado JM, Gomez R, Garcia I, et al. Major bacterial infections following liver transplantation: a prospective study. Hepatogastroenterology. 1992;39(4):362–5.

    PubMed  CAS  Google Scholar 

  95. Blair JE, Kusne S. Bacterial, mycobacterial, and protozoal infections after liver transplantation –part I. Liver Transpl. 2005;11(12):1452–9.

    PubMed  Google Scholar 

  96. Jagadeesh D, Woda BA, Draper J, Evens AM. Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treat Options Oncol. 2012;13(1):122–36.

    PubMed  Google Scholar 

  97. Kamdar KY, Rooney CM, Heslop HE. Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant. 2011;16(3):274–80.

    PubMed  CAS  PubMed Central  Google Scholar 

  98. Savoldo B, Goss JA, Hammer MM, Zhang L, Lopez T, Gee AP, et al. Treatment of solid organ transplant recipients with autologous Epstein Barr virus – specific cytotoxic T lymphocytes (CTLs). Blood. 2006;108:2942–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  99. Kusne S, Blair JE. Viral and fungal infections after liver transplantation – part II. Liver Transpl. 2005;12(1):2–11.

    Google Scholar 

  100. Miloh T, Arnon R, Shneider B, Suchy F, Kerkar N. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol. 2009;7(2):239–45.

    PubMed  Google Scholar 

  101. Miloh T, Anand R, Yin W, Vos M, Kerkar N, Alonso E, et al. Pediatric liver transplantation for primary sclerosing cholangitis (PSC). Liver Transpl. 2011;17(8):925–33.

    PubMed  Google Scholar 

  102. Hadžić N, Quaglia A, Cotoi C, Hussain MJ, Brown N, Vergani D, et al. Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children. Pediatr Transplant. 2012;16(5):501–10.

    PubMed  Google Scholar 

  103. Guido M, Burra P. De novo autoimmune hepatitis after liver transplantation. Semin Liver Dis. 2011;31(1):71–81.

    PubMed  Google Scholar 

  104. Kerkar N, Hadzic N, Davies ET, Portmann B, Donaldson PT, Rela M, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet. 1998;351(9100):409–13.

    PubMed  CAS  Google Scholar 

  105. Miloh T, Arnon R, Roman E, Hurlet A, Kerkar N, Wistinghausen B. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ transplant recipients, report of five cases and review of the literature. Pediatr Transplant. 2011;15(8):870–8.

    PubMed  CAS  Google Scholar 

  106. Shneider BL, Mazariegos GV. Biliary atresia: a transplant perspective. Liver Transpl. 2007;13(11):1482–95.

    PubMed  Google Scholar 

  107. Wallot M. Long-term survival and late graft loss in pediatric liver transplant recipients –a 15-year single-center experience. Liver Transpl. 2002;8(7):615–22.

    PubMed  Google Scholar 

  108. Magee JC, Bucuvalas JC, Farmer DG, Harmon WE, Hulbert-Shearon TE, Mendeloff EN. Pediatric transplantation. Am J Transplant. 2004;4 Suppl 9:54–71.

    PubMed  Google Scholar 

  109. Sokal EM, Veyckemans F, De Ville de Goyet J, Moulin D, Van Hoorebeeck N, Alberti D, et al. Liver transplantation in children less than 1 year of age. J Pediatr. 1990;117(2 Pt 1):205–10.

    PubMed  CAS  Google Scholar 

  110. Soltys KA, Mazariegos GV, Squires RH, Sindhi RK, Anand R, The SPLIT Research Group. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant. 2007;7(9):2165–71.

    PubMed  CAS  Google Scholar 

  111. Maes M, Sokal E, Otte JB. Growth factors in children with end-stage liver disease before and after liver transplantation: a review. Pediatr Transplant. 1997;1(2):171–5.

    PubMed  CAS  Google Scholar 

  112. Sarna S, Laine J, Sipila I, Kolstinen R, Holmberg C. Differences in linear growth and cortisol production between liver and renal transplant recipients on similar immunosuppression. Transplantation. 1995;60:656–61; (Cited 29 Dec 2012).

    PubMed  CAS  Google Scholar 

  113. Bartosh SM, Thomas SE, Sutton MM, Brady LM, Whitington PF. Linear growth after pediatric liver transplantation. J Pediatr. 1999;135(5):624–31.

    PubMed  CAS  Google Scholar 

  114. Codoner-Franch P, Bernard O, Alvarez F. Long-term follow-up of growth in height after successful liver transplantation. J Pediatr. 1994;124(3):368–73.

    PubMed  CAS  Google Scholar 

  115. Mcdiarmid SV, Gornbein JA, DeSilva PJ, Goss JA, Vargas JH, Martín MG, et al. Factors affecting growth after pediatric liver transplantation. Transplantation. 1999;67(3):404–11.

    PubMed  CAS  Google Scholar 

  116. Sorensen L, Neighbors K, Martz K, Zelko F, Bucuvalas JC, Alonso EM. Cognitive and academic outcomes after pediatric liver transplantation: Functional Outcomes Group (FOG) results. Am J Transplant. 2011;11(2):303–11.

    PubMed  CAS  PubMed Central  Google Scholar 

  117. Kaller T, Boeck A, Sander K, Richterich A, Burdelski M, Ganschow R, et al. Cognitive abilities, behaviour and quality of life in children after liver transplantation. Pediatr Transplant. 2009;14(4):496–503.

    Google Scholar 

  118. Grabhorn E, Schulz A, Helmke K, Hinrichs B, Rogiers X, Broering DC, et al. Short- and long-term results of liver transplantation in infants aged less than 6 months. Transplantation. 2004;78(2):235–41.

    PubMed  Google Scholar 

  119. Bucuvalas JC, O'Connor A, Buschle K, Krug S, Ryckman FC, Atherton H, et al. Risk of hearing impairment in pediatric liver transplant recipients: a single center study. Pediatr Transplant. 2003;7(4):265–9.

    PubMed  Google Scholar 

  120. Alonso EM, Neighbors K, Barton FB, Mcdiarmid SV, Dunn SP, Mazariegos GV, et al. Health-related quality of life and family function following pediatric liver transplantation. Liver Transpl. 2008;14(4):460–8.

    PubMed  Google Scholar 

  121. Varni JW, Limbers CA, Sorensen LG, Neighbors K, Martz K, Bucuvalas JC, et al. PedsQL™ cognitive functioning scale in pediatric liver transplant recipients: feasibility, reliability, and validity. Qual Life Res. 2011;20(6):913–21.

    PubMed  PubMed Central  Google Scholar 

  122. Alonso EM, Limbers CA, Neighbors K, Martz K, Bucuvalas JC, Webb T, et al. Cross-sectional analysis of health-related quality of life in pediatric liver transplant recipients. J Pediatr. 2010;156(2):270–1.

    PubMed  PubMed Central  Google Scholar 

  123. Taylor RM, Franck LS, Gibson F, Donaldson N, Dhawan A. Study of the factors affecting healthrelated quality of life in adolescents after liver transplantation. Am J Transplant. 2009;9(5):1179–88.

    PubMed  CAS  Google Scholar 

  124. Nicholas DB, Otley AR, Taylor R, Dhawan A, Gilmour S, Ng VL. Experiences and barriers to health-related quality of life following liver transplantation: a qualitative analysis of the perspectives of pediatric patients and their parents. Health Qual Life Outcomes. 2010;8(1):150.

    PubMed  PubMed Central  Google Scholar 

  125. Kosola S, Lampela H, Lauronen J, Mäkisalo H, Jalanko H, Qvist E, et al. General health, health-related quality of life and sexual health after pediatric liver transplantation: a nationwide study. Am J Transplant. 2011;12(2):420–7.

    PubMed  Google Scholar 

  126. Pagadala M, Dasarathy S, Eghtesad B, Mccullough AJ. Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl. 2009;15(12):1662–70.

    PubMed  Google Scholar 

  127. Dick AAS, Perkins JD, Spitzer AL, Lao OB, Healey PJ, Reyes JD. Impact of obesity on children undergoing liver transplantation. Liver Transpl. 2010;16(11):1296–302.

    PubMed  Google Scholar 

  128. Perito ER, Glidden D, Roberts JP, Rosenthal P. Overweight and obesity in pediatric liver transplant recipients: prevalence and predictors before and after transplant, United Network for Organ Sharing Data, 1987–2010. Pediatr Transplant. 2011;16(1):41–9.

    PubMed  Google Scholar 

  129. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA. 2012;307(5):483–90.

    PubMed  Google Scholar 

  130. Sabate E. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization, editor. 2003:1–211.

    Google Scholar 

  131. Sudan DL, Shaw Jr BW, Langnas AN. Causes of late mortality in pediatric liver transplant recipients. Ann Surg. 1998;227(2):289. Lippincott, Williams, and Wilkins.

    PubMed  CAS  PubMed Central  Google Scholar 

  132. Shemesh E, Shneider BL, Savitzky JK, Arnott L, Gondolesi GE, Krieger NR, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics. 2004;113:825–32.

    PubMed  Google Scholar 

  133. Shemesh E, Annunziato RA, Yehuda R, Shneider BL, Newcorn JH, Hutson C, et al. Childhood abuse, nonadherence, and medical outcome in pediatric liver transplant recipients. J Am Acad Child Adolesc Psychiatry. 2007;46(10):1280–9.

    PubMed  Google Scholar 

  134. Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Non-compliance in children post-liver transplant. Who are the culprits? Pediatr Transplant. 2004;8(3):233–6.

    PubMed  Google Scholar 

  135. Coscia LA, Constantinescu S, Moritz MJ, Radomski JS, Gaughan WJ, McGrory CH, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2007. pp 29–42.

    Google Scholar 

  136. Hoeltzenbein M, Elefant E, Vial T, Finkel-Pekarsky V, Stephens S, Clementi M, et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet A. 2012;158A(3):588–96.

    PubMed  Google Scholar 

  137. Coscia LA, Constantinescu S, Moritz MJ, Frank A, Ramirez CB, Maley WL, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2009:103–22.

    Google Scholar 

  138. Armenti VT, Radomski JS, Moritz MJ, Gaughan WJ, Philips LZ, McGrory CH, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2002:121–30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Gastroenterology and Hepatology, Seattle Children’s Hospital, University of Washington School of Medicine, Seattle, WA, USA

    Evelyn Hsu MD

  2. Division of Transplant Surgery, University of Washington Medical Center, Seattle Children’s Hospital, Seattle, WA, USA

    Jorge Reyes MD

Authors
  1. Evelyn Hsu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorge Reyes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Evelyn Hsu MD .

Editor information

Editors and Affiliations

  1. University of Washington School of Medicine, Seattle Children’s Hospital, Seattle, Washington, USA

    Karen F. Murray

  2. University of Washington School of Medicine, Seattle Children’s Hospital, Seattle, Washington, USA

    Simon Horslen

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hsu, E., Reyes, J. (2014). Liver Transplantation. In: Murray, K., Horslen, S. (eds) Diseases of the Liver in Children. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9005-0_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9005-0_28

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-9004-3

  • Online ISBN: 978-1-4614-9005-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation